Stock News•3 weeks ago
GSK's Specialty Medicines Drive Growth Amid Looming HIV Patent Cliff
GSK's Specialty Medicines are driving growth, but an approaching HIV patent cliff is pushing the company to accelerate its pipeline.
MarketLens
Is GSK's Global Health Focus a Smart Investment Strategy
4 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•1 months ago
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
Moderna's newly approved mFlusiva faces a potential challenge as GSK advances an mRNA flu vaccine targeting two viral proteins, which could intensify competition in the flu vaccine market.
Stock News•2 months ago
GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment
GSK shares fell after the drugmaker dropped its experimental chronic cough treatment due to limited efficacy in late-stage studies.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•1 hour ago
Microsoft (MSFT) Exceeds Market Returns: Some Facts to Consider
Stock News•1 hour ago
Nvidia (NVDA) Outperforms Broader Market: What You Need to Know
Stock News•1 hour ago
Tesla (TSLA) Laps the Stock Market: Here's Why
Stock News•1 hour ago
If you'd bought $10,000 worth of Amazon stock 10 years ago, here's how much you'd have today
Stock News•1 hour ago